BR Biopharma (NASDAQ:BRBI) Shares Up 1.7% – Here’s Why

BR Biopharma, Inc. (NASDAQ:BRBI)’s share price shot up 1.7% during mid-day trading on Monday . The company traded as high as $14.70 and last traded at $14.65. 6,202 shares were traded during trading, an increase of 141% from the average session volume of 2,574 shares. The stock had previously closed at $14.40.

Wall Street Analyst Weigh In

Separately, Weiss Ratings initiated coverage on shares of BR Biopharma in a research report on Friday, February 13th. They issued a “sell (e-)” rating for the company. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company presently has a consensus rating of “Sell”.

BR Biopharma Trading Up 1.7%

BR Biopharma Company Profile

BRBI BR Partners SA, through its subsidiaries, operates as an investment bank which specializes in providing financial services for entrepreneurs and families principally in Brazil. It offers financial advisory services for mergers and acquisitions, capital markets, board services, shareholders, special situations and restructuring, pre-IPO, and privatization; and wealth management services. BRBI BR Partners SA is based in S?o Paulo, Brazil.